Security key
09075P204
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)
CUSIP: 09075P204
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 21,847,524
- Total 13F shares
- 3,538,520
- Share change
- +1,195,942
- Total reported value
- $5,667,324
- Price per share
- $1.60
- Number of holders
- 42
- Value change
- +$1,743,166
- Number of buys
- 23
- Number of sells
- 10
Report period
Q4 2025
Institutions
42
Top holders
10
BTAI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P204
Recent filing periods:
Ownership snapshot
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
INTEGRATED CORE STRATEGIE...
13D/G signal
INTEGRATED CORE STRATEGIE...
Evidence rows
50
Latest as of
31 Dec 2025
13D/G
13F
3/4/5
Lead comparable stake: 8.4%
13D/G row: INTEGRATED CORE STRATEGIES (US) LLC
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
Millennium Management LLC
|
8.4%
|
$3,762,144
1,835,192 shares
|
+$1,654,635 | 31 Dec 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
|
5%
|
$564,737
288,131 shares
|
-$9,229,922 | 31 Mar 2025 |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
Oaktree Capital Holdings, LLC
|
2.7%
|
$28,939
170,230 shares
|
-$434,154 | 31 Mar 2025 |
| Qatar Investment Authority |
13D/G
|
0.6%
|
$26,531
156,066 shares
|
-$436,562 | 31 Dec 2025 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
4.7%
|
$2,631,816
1,028,053 shares
|
— | 30 Sep 2025 |
| OAKTREE CAPITAL MANAGEMENT LP |
13F
Company
|
1.1%
|
$617,443
241,188 shares
|
— | 30 Sep 2025 |
| FMR LLC |
13F
Company
|
0.91%
|
$508,416
198,600 shares
|
— | 30 Sep 2025 |
| VANGUARD GROUP INC |
13F
Company
|
0.88%
|
$491,840
192,125 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
42
Shares
3,538,520
Rows loaded
42
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
35
Q4 2025 holders
42
Holder diff
7
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend